The Role of Abnormal Placentation in Congenital Heart Disease; Cause, Correlate, or Consequence?
The Role of Abnormal Placentation in Congenital Heart Disease; Cause, Correlate, or Consequence?
复制标题
DOI:
10.3389/fphys.2018.01045
复制
发表时间:
2018
影响因子:
4
通讯作者:
Jones HN
中科院分区:
文献类型:
--
作者:
Courtney JA;Cnota JF;Jones HN
Congenital heart disease (CHD) is the most common birth defect, affecting ~1% of all live births (van der Linde et al.,). Despite improvements in clinical care, it is the leading cause of infant mortality related to birth defects (Yang et al.,) and burdens survivors with significant morbidity (Gilboa et al.,). Furthermore, CHD accounts for the largest proportion (26.7%) of birth defect-associated hospitalization costs—up to $6.1 billion in 2013 (Arth et al.,). Yet after decades of research with a primary focus on genetic etiology, the underlying cause of these defects remains unknown in the majority of cases (Zaidi and Brueckner,). Unexplained CHD may be secondary to undiscovered roles of noncoding genetic, epigenetic, and environmental factors, among others (Russell et al.,). Population studies have recently demonstrated that pregnancies complicated by CHD also carry a higher risk of developing pathologies associated with an abnormal placenta including growth disturbances (Puri et al.,), preeclampsia (Auger et al.,; Brodwall et al.,), preterm birth (Laas et al.,), and stillbirth (Jorgensen et al.,). Both the heart and placenta are vascular organs and develop concurrently; therefore, shared pathways almost certainly direct the development of both. The involvement of placental abnormalities in congenital heart disease, whether causal, commensurate or reactive, is under investigated and given the common developmental window and shared developmental pathways of the heart and placenta and concurrent vasculature development, we propose that further investigation combining clinical data, in vitro, in vivo, and computer modeling is fundamental to our understanding and the potential to develop therapeutics.
登录
查看更多内容
影响因子:
30.8
作者:
Bamforth, SD;Bragança, J;Bhattacharya, S
通讯作者:
Bhattacharya, S
DOI:
10.1016/j.ejogrb.2015.06.024
发表时间:
2015-10-01
影响因子:
2.6
作者:
Czeizel, Andrew E.;Vereczkey, Attila;Szabo, Istvan
通讯作者:
Szabo, Istvan
影响因子:
16
作者:
Barak, Y;Nelson, MC;Evans, RM
通讯作者:
Evans, RM
DOI:
10.15585/mmwr.mm6602a1
发表时间:
2017-01-20
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Arth AC;Tinker SC;Simeone RM;Ailes EC;Cragan JD;Grosse SD
通讯作者:
Grosse SD
影响因子:
5.4
作者:
Best KE;Tennant PWG;Rankin J
通讯作者:
Rankin J